NSG 6320 AGNP BOARD EXAM QUESTIONS Womens Health Prescription (NSG 6320 AGNP_BOARD_EXAM_QUESTIONSWomens_Health_Prescription)
Southern University
Hier vind je de beste samenvattingen om te slagen voor NSG 6320 AGNP BOARD EXAM QUESTIONS Womens Health Prescription (NSG 6320 AGNP_BOARD_EXAM_QUESTIONSWomens_Health_Prescription). Er zijn o.a. samenvattingen, aantekeningen en oefenvragen beschikbaar.
Alle 1 resultaten
Sorteer op
-
NSG 6320 AGNP_BOARD_EXAM_QUESTIONS_and ANSWERS Womens_Health_Prescription 100% CORRECT
- Tentamen (uitwerkingen) • 31 pagina's • 2021
- $14.49
- + meer info
AGNP BOARD EXAM QUESTIONS Womens Health Prescription (101 Questions)
Question:
Which of the following is NOT a common side effect associated with the use of
etonogestrel/ethinyl estradiol (NuvaRing), a contraceptive vaginal ring?
Vaginitis
Breast tenderness
Increased appetite
Severe headache Correct
Explanation:
A common side effect NOT associated with the use of etonogestrel/ethinyl estradiol
(NuvaRing) is severe headache. The systemic side effects of NuvaRing are the same as
with or...
Tentamen (uitwerkingen)
NSG 6320 AGNP_BOARD_EXAM_QUESTIONS_and ANSWERS Womens_Health_Prescription 100% CORRECT
Laatste update van het document:
geleden
AGNP BOARD EXAM QUESTIONS Womens Health Prescription (101 Questions) Question: Which of the following is NOT a common side effect associated with the use of etonogestrel/ethinyl estradiol (NuvaRing), a contraceptive vaginal ring? Vaginitis Breast tenderness Increased appetite Severe headache Correct Explanation: A common side effect NOT associated with the use of etonogestrel/ethinyl estradiol (NuvaRing) is severe headache. The systemic side effects of NuvaRing are the same as with or...
$14.49
In winkelwagen
